Literature DB >> 12368382

Procedure guideline for lymphoscintigraphy and the use of intraoperative gamma probe for sentinel lymph node localization in melanoma of intermediate thickness 1.0.

Naomi Alazraki1, Edwin C Glass, Frank Castronovo, Renato A Valdés Olmos, Donald Podoloff.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12368382

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  13 in total

Review 1.  SPECT/CT and tumour imaging.

Authors:  Gad Abikhzer; Zohar Keidar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-08-29       Impact factor: 9.236

2.  Radioguided sentinel lymph node dissection in patients with localised prostate carcinoma: influence of the dose of radiolabelled colloid to avoid failure of the procedure.

Authors:  Isabelle Brenot-Rossi; Dominique Rossi; Benjamin Esterni; Serge Brunelle; Guillaume Chuto; Cyrille Bastide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-09       Impact factor: 9.236

3.  EANM-EORTC general recommendations for sentinel node diagnostics in melanoma.

Authors:  Annette H Chakera; Birger Hesse; Zeynep Burak; James R Ballinger; Allan Britten; Corrado Caracò; Alistair J Cochran; Martin G Cook; Krzysztof T Drzewiecki; Richard Essner; Einat Even-Sapir; Alexander M M Eggermont; Tanja Gmeiner Stopar; Christian Ingvar; Martin C Mihm; Stanley W McCarthy; Nicola Mozzillo; Omgo E Nieweg; Richard A Scolyer; Hans Starz; John F Thompson; Giuseppe Trifirò; Giuseppe Viale; Sergi Vidal-Sicart; Roger Uren; Wendy Waddington; Arturo Chiti; Alain Spatz; Alessandro Testori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10       Impact factor: 9.236

4.  EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.

Authors:  Christina Bluemel; Ken Herrmann; Francesco Giammarile; Omgo E Nieweg; Julien Dubreuil; Alessandro Testori; Riccardo A Audisio; Odysseas Zoras; Michael Lassmann; Annette H Chakera; Roger Uren; Sotirios Chondrogiannis; Patrick M Colletti; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-25       Impact factor: 9.236

5.  The impact of nodal tumour burden on lymphoscintigraphic imaging in patients with melanomas.

Authors:  Lutz Kretschmer; Hans Peter Bertsch; Pawel Bardzik; Johannes Meller; Simin Hellriegel; Kai-Martin Thoms; Michael Peter Schön; Carsten Oliver Sahlmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-10-15       Impact factor: 9.236

6.  New approaches to lymphatic imaging.

Authors:  Richard T Lucarelli; Mikako Ogawa; Nobuyuki Kosaka; Baris Turkbey; Hisataka Kobayashi; Peter L Choyke
Journal:  Lymphat Res Biol       Date:  2009-12       Impact factor: 2.589

7.  The diagnostic value of adding dynamic scintigraphy to standard delayed planar imaging for sentinel node identification in melanoma patients.

Authors:  Kristina Rue Nielsen; Annette H Chakera; Birger Hesse; Richard A Scolyer; Jonathan F Stretch; John F Thompson; Michael B Nielsen; Roger F Uren; Peter S Oturai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-17       Impact factor: 9.236

8.  Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT.

Authors:  H Lerman; U Metser; G Lievshitz; F Sperber; S Shneebaum; E Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-12       Impact factor: 9.236

9.  Sentinel lymph node detection following the hysteroscopic peritumoural injection of 99mTc-labelled albumin nanocolloid in endometrial cancer.

Authors:  Marco Maccauro; Giovanni Lucignani; Gianluca Aliberti; Carlo Villano; Maria Rita Castellani; Eugenio Solima; Emilio Bombardieri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-30       Impact factor: 9.236

10.  Practice variation in defining sentinel lymph nodes on lymphoscintigrams in oral cancer patients.

Authors:  Géke B Flach; Annelies van Schie; Birgit I Witte; Renato A Valdés Olmos; W Martin C Klop; Otto S Hoekstra; Remco de Bree
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-07-08       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.